Abbott Laboratories (ABT) Dividends payables (2009 - 2026)

Abbott Laboratories has disclosed Dividends payables across 18 years of filings, most recently posting $1.1 billion for Q2 2026.

• In Q2 2026, Dividends payables rose 6.12% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (up 6.12% YoY), while the FY2025 annual figure was $1.1 billion, up 7.13% from the prior year.
• Dividends payables came in at $1.1 billion for Q2 2026 at Abbott Laboratories, down from $1.1 billion in the prior quarter.
• In the past five years, Dividends payables ranged from a high of $1.1 billion in Q1 2026 to a low of $820.0 million in Q3 2022.
• Average Dividends payables over 5 years is $958.3 million, with a median of $957.5 million recorded in 2024.
• Year-over-year, Dividends payables climbed 2.87% in 2022 and gained 8.24% in 2024.
• Over 5 years, Dividends payables stood at $887.0 million in 2022, then increased by 7.67% to $955.0 million in 2023, then increased by 7.23% to $1.0 billion in 2024, then grew by 7.13% to $1.1 billion in 2025, then dropped by 0.36% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Dividends payables figures were $1.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.1 billion in Q4 2025.